Erstautorschaften und Seniorautorschaften




FDG-PET/MRI imaging for the management of alveolar echinococcosis: initial clinical experience at a reference centre in Austria.

Lötsch F, Waneck F, Groger M, Auer H, Kaczirek K, Rausch I, Wadsak W, Hacker M, Lagler H, Ramharter M, Karanikas G.

Trop Med Int Health. 2019. IF: 2,46

[18F]FDG-PET/CT and MRI for initial pelvic lymph node staging in patients with cervical carcinoma: The potential usefulness of [18F]FDG-PET/MRI.

Anner P, Mayerhöfer M, Wadsak W, Geleff S, Dudczak R, Haug A, Hacker M, Karanikas G.

Oncol Lett. 2018. IF: 1,97

Clinical Value of 18F-FDOPA PET/CT With Contrast Enhancement and Without Carbidopa Premedication in Patients with Insulinoma.

Nakuz TS, Berger E, El-Rabadi K, Wadsak W, Haug A, Hacker M, Karanikas G.

 Anticancer Res. 2018. IF: 1,98

Clinical Value of 18F-fluorodihydroxyphenylalanine Positron Emission Tomography/Contrast-enhanced Computed Tomography (18F-DOPA PET/CT) in Patients with Suspected Paraganglioma.

El-Rabadi K, Weber M, Mayerhofer M, Nakuz T, Scherer T, Mitterhauser M, Dudczak R, Hacker M, Karanikas G.

Anticancer Res. 2016. IF: 2,06

Relevance of calcitonin cut-off in the follow-up of medullary thyroid carcinoma for conventional imaging and 18-fluorine-
fluorodihydroxyphenylalanine PET.

Sesti A, Mayerhoefer M, Weber M, Anner P, Wadsak W, Dudczak R, Haug A, Karanikas G.

Anticancer Res. 2014. IF: 2,14

¹C-acetate PET/CT imaging: physiologic uptake,
variants, and pitfalls.

Karanikas G, Beheshti M.

PET Clin. 2014. IF: 0.19

(18)F-DOPA PET/CT and MRI: description of 12
histologically-verified pheochromocytomas.

Magnaldi S, Mayerhoefer ME, Khameneh A, Schuetz M, Javor D, Mitterhauser M, Dudczak R, Hacker M, Karanikas G.

Anticancer Res. 2014. IF: 2,14

Gadoxetate-enhanced versus diffusion-weighted MRI for fused Ga-68-DOTANOC PET/MRI in patients with neuroendocrine tumours of the upper abdomen.

Mayerhoefer ME, Ba-Ssalamah A, Weber M, Mitterhauser M, Eidherr H, Wadsak W, Raderer M, Trattnig S, Herneth A, Karanikas G.

Eur Radiol. 2013. IF: 5,11

eta-2 microglobulin as a diagnostic parameter in non-Hodgkin lymphoma: a comparative study with FDG-PET.

Toth DF, Raderer M, Wadsak W, Karanikas G.

Anticancer Res. 2013. IF: 2,2

Are contrast media required for (68)Ga-DOTATOC PET/CT in patients with neuroendocrine tumours of the abdomen?

Mayerhoefer ME, Schuetz M, Magnaldi S, Weber M, Trattnig S, Karanikas G.

Eur Radiol. 2012. IF: 4.11

Assessment of pulmonary melanoma metastases with (18)F-FDG PET/CT: which PET-negative patients require additional tests for definitive staging?

Mayerhoefer ME, Prosch H, Herold Ch, Weber M and Karanikas G.

Eur Radiol in press 2012. IF: 3.594

Are contrast media required for (68)Ga-DOTATOC PET/CT in patients with neuroendocrine tumours of the abdomen?

Mayerhoefer ME, Schuetz M, Magnaldi S, Weber M, Trattnig S, Karanikas G.

Eur Radiol 2011. IF: 3.594

No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis.

Karanikas G, Schuetz M, Kontur S, Duan H, Kommata S, Schon R, Antoni A, Kletter K, Dudczak R,  Willheim M.

Thyroid 2008; 18:7-12. IF: 4.327

[(18)F]FETO for adrenocortical PET imaging: a pilot study in healthy  volunteers.

Wadsak W, Mitterhauser M, Rendl G, Schuetz M, Mien LK, Ettlinger DE, Dudczak R, Kletter K, Karanikas G.

Eur J Nucl Med 2006. IF: 5.036

Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto’s thyroiditis.

Karanikas G, Schuetz M, Wahl K, Paul M, Kontur S, Pietschmann P, Kletter K, Dudczak R, Willheim M.

Clin Endocrinol (Oxf) 2005; 63:191-6. IF: 3.607

Platelet kinetics and scintigraphic imaging in thrombocytopenic malaria patients.

Karanikas G, Zedwitz-Liebenstein K, Eidherr H, Schuetz M, Sauerman R, Dudczak R, Winkler S, Pabinger I, Kletter K.

Thromb Haemost 2004; 91:553-7. IF: 4.701

Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects.

Karanikas G, Moameni A, Poetzi C, Zettinig G, Kaserer K, Bieglmayer C, Niederle B, Dudczak R, Pirich Ch.

J Clin Endocrinol Metab 2004; 89:515-9. IF: 6.495

Isotopic renal function studies in severe hypothyroidism and after thyroid hormone replacement therapy.

Karanikas G, Schutz M, Szabo M, Becherer A, Wiesner K, Dudczak R, Kletter K.

Am J Nephrol 2004; 24:41-5. IF: 2.658

T lymphocyte cytokine production patterns in non-immune severe hypothyroid state and after thyroid hormone replacement therapy.

Karanikas G, John Ph, Wahl K, Schuetz M, Dudczak R, Willheim M.

Thyroid 2004; 14:488-492. IF: 4.327

ACE inhibition is superior to angiotensin receptor blockade for renography in renal artery stenosis.

Karanikas G, Becherer A, Wiesner K, Dudczak R, Kletter K.

Eur J Nucl Med 2002; 29:312-8. IF: 5.036

Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma.

Karanikas G, Köstler WJ, Becherer A, Wiesner K, Dudczak R, Krainer M, Kletter K.

Oncol Rep 2002; 9:1009-13. IF: 1.686

Nuclear Medicine in the Diagnosis of Renovascular Disease.

Karanikas G.

Imaging Decisions 2002; 2:37-40. (Review)

Imaging of primitive neuroectodermal tumor (PNET) by technetium-99m tetrofosmin.

Karanikas G, Köstler W, Becherer A, Dudczak R, Krainer M, Kletter K.

Sarcoma 2001; 5:215-6. (Case report)

Examination of Co-complexes for radiolabeling of platelets in positron emission tomographic studies.

Karanikas G, Schmaljohann J, Rodrigues M, Chehne F, Granegger S, Sinzinger H.

Thromb Res 1999; 15;94:111-5. IF: 2.372

In-vitro studies on the usefulness of 99mTc-tetrofosmin for sarcoma detection.

Karanikas G, Berghammer P, Rodrigues M, Chehne F, Sinzinger H.

Radioactive Isotopes in Clinical Medicine and Research XXIII, Birkhäuser Verlag, 1999; 391-4. (Kongressbuchbeitrag)

Platelet labeling with 67Ga-MPO: a comparison with 111In-MPO.

Karanikas G, Rodrigues M, Granegger S, Havlik E, Sinzinger H.

Nucl Med Biol 1998; 25:165-8. IF: 2.620

No relevance for 67Ga – tropolone platelet labeling. A comparison with 111In – tropolone.

Karanikas G, Rodrigues M, Granegger S, Sinzinger H.

Rev Iberoamer Tromb Hemostasia 1997; 10:53-7. (Nicht gelistetes Journal)

Vascular wall-rather than platelet PGE1-pretreatment in-vivo (but not in-vitro) decreases thrombogenicity.

Karanikas G, Granegger S, Schima H, Sinzinger H.

dv Exp Med Biol 1997; 433:431-4. IF: 1.379

Correction of increased thrombogenic potential with cholesterol reduction is mainly due to vascular wall.

Karanikas G, Kritz H, Granegger S, Sinzinger H.

Circulation 1997; 96:2097-9. (Letter, IF: 14.432)

99mTc-d, 1-ciclobutilprooilenoaminaoxima (99mTc-CBPAO) nậo apresenta vantagens relativamente a 99mTC-hexametilpropilenoaminaoxima (99mTc-HMPAO) para a marçacao de plaquetas.

Karanikas G, Rodrigues M, Granegger S, Oguogho A, Sinzinger H.

Rev Esp Med Nucl 1997; 16:1-5. IF: 0.770

Platelet labeling with 67Ga (67Ga-Oxine,-Tropolone,-MPO).

Karanikas G, Rodrigues M, Granegger S, Havlik E, Sinzinger H.

Radioactive Isotopes in Clinical Medicine and Research XXII, Birkhäuser Verlag, 1997; 427-31. (Kongressbuchbeitrag)

Platelet uptake of 131I-metaiodobenzylguanidine-mechanism, extent and clinical relevance.

Karanikas G, Rodrigues M, Granegger S, Havlik E, Sinzinger H.

Radioactive Isotopes in Clinical Medicine and Research, Birkhäuser Verlag, 1995; 09-13. (Kongressbuchbeitrag)





Diagnostic Role of PET/CT Tracers in the Detection and Localization of Tumours Responsible for Ectopic Cushing’s Syndrome.

Zisser L, Kulterer O, Itariu B, Fueger B, Weber M, Mazal P, Vraka C1, Pichler V, Kautzky-Willer A, Hacker M, Karanikas G, Rasul S

Breast Tumor Characterization Using [ 18 F]FDG-PET/CT Imaging Combined with Data Preprocessing and Radiomics.

Krajnc D, Papp L, Nakuz T, Magometschnigg H, Grahovac M, Spielvogel C, Ecsedi B, Bago-Horvath Z, Haug A, Karanikas G, Beyer T, Hacker M, Helbich H, Pinker K

Cancer (Basel). 2021 Mar 12;13(6):1249.

Human Biodistribution and Radiation Dosimetry of the P-Glycoprotein Radiotracer [11C]Metoclopramide.

Barner M, Barna S, Blaickner M, Prosenz K, Bamminger K, Pichler V, Tournier N, Hacker M, Zeitlinger MKaraniaks G, Langer O

Molecular Imaging and Biology. Apr;23(2):180-185. 

Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in Large Arteries.

Calabretta R, Hoeller C, Pichler V, Mitterhauser M, Karanikas G, Haug A, Li X, Hacker M.

Circulation. 2020 Dec 15;142(24):2396-2398.

The relationship between cholecystokinin secretion
and pancreatic [11C]methionine uptake in patients after partial pancreaticoduodenectomy.

Steiner E, Kazianka L, Breuer R, Hacker M, Wadsak W, Mitterhauser M, Rehfeld JF, Karanikas G, Miholic J.

Ann Nucl Med. 2020 Sep;34(9):691-695.

PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations.

Mayerhoefer ME, Prosch H, Beer L, Tamandl D, Beyer T, Hoeller C, Berzaczy D, Raderer M, Preusser M, Hochmair M, Kiesewetter B, Scheuba C, Ba-Ssalamah A, Karanikas G, Kesselbacher J, Prager G, Dieckmann K, Polterauer S, Weber M, Rausch I, Brauner B, Eidherr H, Wadsak W, Haug AR.

 Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):51-60.

Characterization of Bone Lesions in Myeloma Before and During Anticancer Therapy Using 18F-FDG-PET/CT and 18F-NaF-PET/CT.

Nakuz TS, Millinger FP, El-Rabadi K, Weber M, Pichler V, Wadsak W, Mitterhauser M, Haug A, Hacker M, Karanikas G, Pietschmann P, Agis H.

Anticancer Res. 2019 Apr;39(4):1943-1952.

 [11C]acetate PET as a
tool for diagnosis of liver steatosis.

Nejabat M, Leisser A, Karanikas G, Wadsak W, Mitterhauser M, Mayerhöfer M, Kienbacher C, Trauner M, Hacker M, Haug AR.

Abdom Radiol (NY). 2018 Nov;43(11):2963-2969.

Medullary Thyroid Carcinoma: Do Ultrasonography and
F-DOPA-PET-CT Influence the Initial Surgical Strategy?

Brammen L, Niederle MB, Riss P, Scheuba C, Selberherr A, Karanikas G, Bodner G, Koperek O, Niederle B.

Ann Surg Oncol. 2018 Dec;25(13):3919-3927.

[18F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery.

Rasul S, Hartenbach S, Rebhan K, Göllner A, Karanikas G, Mayerhoefer M, Mazal P, Hacker M, Hartenbach M.

Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2159-2169.

Visual and semiquantitative 11C-methionine PET: an
independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomas.

 Poetsch N, Woehrer A, Gesperger J, Furtner J, Haug AR, Wilhelm D, Widhalm G, Karanikas G, Weber M, Rausch I, Mitterhauser M, Wadsak W, Hacker M, Preusser M, Traub-Weidinger T.

Neuro Oncol. 2018 Feb 19;20(3):411-419.

Changes in Tumor Biology During Chemoradiation of Cervix Cancer Assessed by Multiparametric MRI and Hypoxia PET.

Georg P, Andrzejewski P, Baltzer P, Daniel M, Wadsak W, Mitterhauser M, Sturdza A, Majercakova K, Karanikas G, Pötter R, Hacker M, Helbich T, Georg D,
Pinker K.

Mol Imaging Biol. 2018 Feb;20(1):160-169.

Bone Marrow Involvement in Malignant Lymphoma:
Evaluation of Quantitative PET and MRI Biomarkers.

 Asenbaum U, Nolz R, Karanikas G, Furtner J, Woitek R, Simonitsch-Klupp I, Raderer M, Mayerhoefer ME.

 Acad Radiol. 2018 Apr;25(4):453-460.

Correlation between glycolytic activity on [18F]-FDG-PET and cell density on diffusion-weighted MRI in lymphoma at staging.


Giraudo C, Karanikas G, Weber M, Raderer M, Jaeger U, Simonitsch-Klupp I, Mayerhoefer ME.

J Magn Reson Imaging. 2018 May;47(5):1217-1226.

FDG-PET/MRI in alveolar echinococcosis.

Lötsch F, Waneck F, Auer H, Kaczirek K, Karanikas G, Ramharter M.

Int J Infect Dis. 2017 Nov;64:67-68.

Tumor-associated B-cells induce tumor heterogeneity and therapy resistance.

Somasundaram R, Zhang G, Fukunaga-Kalabis M, Perego M, Krepler C, Xu X, Wagner C, Hristova D, Zhang J, Tian T, Wei Z, Liu Q, Garg K, Griss J, Hards R, Maurer M, Hafner C, Mayerhöfer M, Karanikas G, Jalili A, Bauer-Pohl V, Weihsengruber F, Rappersberger K, Koller J, Lang R, Hudgens C, Chen G, Tetzlaff M, Wu L, Frederick DT, Scolyer RA, Long GV, Damle M, Ellingsworth C, Grinman L, Choi H, Gavin BJ, Dunagin M, Raj A, Scholler N, Gross L, Beqiri M, Bennett K,
Watson I, Schaider H, Davies MA, Wargo J, Czerniecki BJ, Schuchter L, Herlyn D, Flaherty K, Herlyn M, Wagner SN.

Nat Commun. 2017 Sep 19;8(1):607.

Whole-Body 68Ga-DOTANOC PET/MRI Versus 68Ga-DOTANOC PET/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 Patients.

Berzaczy D, Giraudo C, Haug AR, Raderer M, Senn D, Karanikas G, Weber M, Mayerhoefer ME.

Clin Nucl Med. 2017 Sep;42(9):669-674.

Multiparametric [11C]Acetate positron emission tomography-magnetic resonance imaging in the assessment and staging of prostate cancer.

Polanec SH, Andrzejewski P, Baltzer PAT, Helbich TH, Stiglbauer A, Georg D, Karanikas G, Susani M, Wadsak W, Margreiter M, Mitterhauser M, Brader P, Pinker K.

PLoS One. 2017 Jul 18;12(7):e0180790.

Association Between Osteogenesis and Inflammation During the Progression of Calcified Plaque Evaluated by <sup>18</sup>F-Fluoride and <sup>18</sup>F-FDG.

Li X, Heber D, Cal-Gonzalez J, Karanikas G, Mayerhoefer ME, Rasul S, Beitzke D, Zhang X, Agis H, Mitterhauser M, Wadsak W, Beyer T, Loewe C, Hacker M.

J Nucl Med. 2017 Jun;58(6):968-974.

Influence of PET reconstruction technique and matrix size on qualitative and quantitative assessment of lung lesions on [18F]-FDG-PET: A prospective study in 37 cancer patients.

Riegler G, Karanikas G, Rausch I, Hirtl A, El-Rabadi K, Marik W, Pivec C, Weber M, Prosch H, Mayerhoefer M.

Eur J Radiol. 2017 May;90:20-26.

Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients.

Mayerhoefer ME, Karanikas G, Kletter K, Kiesewetter B, Weber M, Rausch I, Pones M, Simonitsch-Klupp I, Müllauer L, Dolak W, Lukas J, Raderer M.

Clin Nucl Med. 2016 Nov;41(11):837-843.

Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging.

Asenbaum U, Nolz R, Karanikas G, Furtner J, Woitek R, Staudenherz A, Senn D, Raderer M, Weber M, Simonitsch-Klupp I, Mayerhoefer ME.

 PLoS One. 2016 Oct 10;11(10):e0164118.

Fever of unknown origin (FUO) revised.

Unger M, Karanikas G, Kerschbaumer A, Winkler S, Aletaha D.

Wien Klin Wochenschr. 2016 Nov;128(21-22):796-801.

Presurgical evaluation of pediatric epilepsy patients prior to hemispherotomy: the prognostic value of 18F-FDG PET.

Traub-Weidinger T, Weidinger P, Gröppel G, Karanikas G, Wadsak W, Kasprian G, Dorfer C, Dressler A, Muehlebner A, Hacker M, Czech T, Feucht M.

J Neurosurg Pediatr. 2016 Dec;25(6):683-688.

**-Postprandial pancreatic [11C]methionine uptake after pancreaticoduodenectomy mirrors basal beta cell function and insulin release.

Steiner E, Kazianka L, Breuer R, Hacker M, Wadsak W, Mitterhauser M, Stimpfl T, Reiter B, Karanikas G, Miholic J.

Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):509-516.

Quantitative Assessment of Breast Parenchymal
Uptake on 18F-FDG PET/CT: Correlation with Age, Background Parenchymal Enhancement, and Amount of Fibroglandular Tissue on MRI.

Leithner D, Baltzer PA, Magometschnigg HF, Wengert GJ, Karanikas G, Helbich TH, Weber M, Wadsak W, Pinker K.

 J Nucl Med. 2016 Oct;57(10):1518-1522.

Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study.

 Pinker K, Andrzejewski P, Baltzer P, Polanec SH, Sturdza A, Georg D, Helbich TH, Karanikas G, Grimm C, Polterauer S, Poetter R, Wadsak W, Mitterhauser M,
Georg P.

PLoS One. 2016 May 11;11(5):e0155333.

18F-Fluorodeoxyglucose Positron Emission
Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.

Giraudo C, Raderer M, Karanikas G, Weber M, Kiesewetter B, Dolak W, Simonitsch-Klupp I, Mayerhoefer ME.

Invest Radiol. 2016 Mar;51(3):163-9.

Evaluation of fatty acid synthase in prostate cancer recurrence: SUV of [(11) C]acetate PET as a prognostic marker.

Leisser A, Pruscha K, Ubl P, Wadsak W, Mayerhöfer M, Mitterhauser M, Hacker M, Kramer G, Shariat S, Karanikas G, Hartenbach M, Haug AR.

Prostate. 2015 Nov;75(15):1760-7.

Erratum: „Three-dimensional texture analysis of contrast enhanced CT images for treatment response assessment in Hodgkin lymphoma: Comparison with F-18-FDG PET“

Knogler T, El-Rabadi K, Weber M, Karanikas G, Mayerhoefer ME.

ed Phys. 2015 Aug;42(8):4998.

Schutz des ungeborenen Lebens bei diagnostischen und interventionellen radiologischen Verfahren [Protection of the unborn child in diagnostic and interventional radiological procedures].

Hojreh A, Prosch H, Karanikas G, Homolka P, Trattnig S.

Radiologe. 2015 Aug;55(8):663-72.

Diagnostic accuracy of (18)F-FDG PET/CT compared
with that of contrast-enhanced MRI of the breast at 3 T.

Magometschnigg HF, Baltzer PA, Fueger B, Helbich TH, Karanikas G, Dubsky P, Rudas M, Weber M, Pinker K.

Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1656-1665.

microRNA-21 expression is elevated in esophageal adenocarcinoma after neoadjuvant chemotherapy.

Ilhan-Mutlu A, Tezcan G, Schoppmann SF, Preusser M, Spyridoula K, Karanikas G, Birner P.

Cancer Invest. 2015 Jul;33(6):246-50.

Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT-Controlled Prospective Study in 64 Patients.

Mayerhoefer ME, Karanikas G, Kletter K, Prosch H, Kiesewetter B, Skrabs C, Porpaczy E, Weber M, Knogler T, Sillaber C, Jaeger U, Simonitsch-Klupp I, Ubl P, Müllauer L, Dolak W, Lukas J, Raderer M.

Clin Cancer Res. 2015 Jun 1;21(11):2506-13.

Hepatic dysfunction contributes to coagulation disturbances in patients undergoing whole body hyperthermia by use of extracorporeal circulation.

Worel N, Knöbl P, Karanikas G, Fuchs EM, Bojic A, Brodowicz T, Jilma P, Zielinski CC, Köstler WJ, Locker GJ.

 Int J Artif Organs. 2014 Sep;37(9):1-12.

11C-methionine PET/CT imaging of 99mTc- MIBI-SPECT/CT-negative patients with primary hyperparathyroidism and previous neck surgery.

Traub-Weidinger T, Mayerhoefer ME, Koperek O, Mitterhauser M, Duan H, Karanikas G, Niederle B, Hoffmann M.

J Clin Endocrinol Metab. 2014 Nov;99(11):4199-205.

Improved differentiation of benign and malignant breast tumors with multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging: a feasibility study.

Pinker K, Bogner W, Baltzer P, Karanikas G, Magometschnigg H, Brader P, Gruber S, Bickel H, Dubsky P, Bago-Horvath Z, Bartsch R, Weber M, Trattnig S, Helbich TH.

Clin Cancer Res. 2014 Jul 1;20(13):3540-9.

Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression.

Hahn A, Haeusler D, Kraus C, Höflich AS, Kranz GS, Baldinger P, Savli M, Mitterhauser M, Wadsak W, Karanikas G, Kasper S, Lanzenberger R.

Hum Brain Mapp. 2014 Aug;35(8):3857-66.

Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.

Mayerhoefer ME, Karanikas G, Kletter K, Prosch H, Kiesewetter B, Skrabs C, Porpaczy E, Weber M, Pinker-Domenig K, Berzaczy D, Hoffmann M, Sillaber C, Jaeger U, Müllauer L, Simonitsch-Klupp I, Dolak W, Gaiger A, Ubl P, Lukas J, Raderer M.

Clin Cancer Res. 2014 Jun 1;20(11):2984-93.

Rapid detection of bone metastasis at thoracoabdominal CT: accuracy and efficiency of a new visualization algorithm.

Toth DF, Töpker M, Mayerhöfer ME, Rubin GD, Furtner J, Asenbaum U, Karanikas G, Weber M, Czerny C, Herold CJ, Ringl H.

Radiology. 2014 Mar;270(3):825-33.

Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET.

Lanzenberger R, Baldinger P, Hahn A, Ungersboeck J, Mitterhauser M, Winkler D, Micskei Z, Stein P, Karanikas G, Wadsak W, Kasper S, Frey R.

Mol Psychiatry. 2013 Jan;18(1):93-100.

Impact of electroconvulsive therapy on 5-HT1A receptor binding in major depression.

Lanzenberger R, Baldinger P, Hahn A, Ungersboeck J, Mitterhauser M, Winkler D, Micskei Z, Stein P, Karanikas G, Wadsak W, Kasper S, Frey R.

Mol Psychiatry. 2013 Jan;18(1):1.

Application of image-derived and venous input functions in major depression using [carbonyl-(11)C]WAY-100635.

Hahn A, Nics L, Baldinger P, Wadsak W, Savli M, Kraus C, Birkfellner W, Ungersboeck J, Haeusler D, Mitterhauser M, Karanikas G, Kasper S, Frey R, Lanzenberger R.

Nucl Med Biol. 2013 Apr;40(3):371-7.

Preparation and First Preclinical Evaluation of [(18)F]FE@SNAP: A Potential PET Tracer for the Melanin-Concentrating Hormone Receptor-1 (MCHR1).

Philippe C, Nics L, Zeilinger M, Schirmer E, Spreitzer H, Karanikas G, Lanzenberger R, Viernstein H, Wadsak W, Mitterhauser M.

Sci Pharm. 2013 Jul 1;81(3):625-39.

Reliable set-up for in-loop ¹¹C-carboxylations using Grignard reactions for the preparation of [carbonyl-¹¹C]WAY-100635 and [¹¹C]-(+)-PHNO.

Rami-Mark C, Ungersboeck J, Haeusler D, Nics L, Philippe C, Mitterhauser M, Willeit M, Lanzenberger R, Karanikas G, Wadsak W.

Appl Radiat Isot. 2013 Dec;82:75-80.

In search of acute surgical stress biomarkers: Is ghrelin a potential candidate?

Kontoravdis N, Vassilikostas G, Lagoudianakis EE, Pappas A, Seretis C, Panagiotopoulos N, Koronakis N, Chrysikos J, Karanikas G, Manouras I, Legakis I, Voros D.

J Res Med Sci. 2013 Nov;18(11):1016-7.

Combining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C]WAY-100635 independent of arterial sampling.

 Hahn A, Nics L, Baldinger P, Ungersböck J, Dolliner P, Frey R, Birkfellner W, Mitterhauser M, Wadsak W, Karanikas G, Kasper S, Lanzenberger R.

Neuroimage. 2012 Aug 1;62(1):199-206.

Effect of Acute Surgical Stress on Serum Ghrelin Levels.

Kontoravdis N, Vassilikostas G, Lagoudianakis E, Pappas A, Seretis C, Panagiotopoulos N, Koronakis N, Chrysikos J, Karanikas G, Manouras I, Legakis I, Voros D.

Gastroenterology Res. 2012 Jun;5(3):97-102.

Radiosynthesis of [11C]SNAP-7941–the first PET-tracer for the melanin concentrating hormone receptor 1 (MCHR1).

Philippe C, Schirmer E, Mitterhauser M, Shanab K, Lanzenberger R, Karanikas G, Spreitzer H, Viernstein H, Wadsak W.

Appl Radiat Isot. 2012 Oct;70(10):2287-94.

Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas.

anzenberger R, Kranz GS, Haeusler D, Akimova E, Savli M, Hahn A, Mitterhauser M, Spindelegger C, Philippe C, Fink M, Wadsak W, Karanikas G, Kasper S.

Neuroimage. 2012 Nov 1;63(2):874-81.

[¹⁸F]FE-SNAP-A new PET tracer for the melanin concentrating hormone receptor 1 (MCHR1): microfluidic and vessel-based approaches.

Philippe C, Ungersboeck J, Schirmer E, Zdravkovic M, Nics L, Zeilinger M, Shanab K, Lanzenberger R, Karanikas G, Spreitzer H, Viernstein H, Mitterhauser M, Wadsak W.

Bioorg Med Chem. 2012 Oct 1; 20(19):5936-40.

Differential modulation of the default mode network via serotonin-1A receptors.

Hahn A, Wadsak W, Windischberger C, Baldinger P, Höflich A, Losak J, Nics L, Philippe C, Kranz G, Kraus C, Mitterhauser M, Karanikas G, Kasper S, Lanzenberger R.

Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2619-24.

The effect of device-based cardiac contractility modulation therapy on myocardial efficiency and oxidative metabolism in patients with heart failure.

Goliasch G, Khorsand A, Schütz M, Karanikas G, Khazen C, Sochor H, Schmidinger H, Wolzt M, Graf S.

Eur J Nucl Med Mol Imaging. 2012 Mar;39(3):408-15.

Assessment of left ventricular volumes, ejection fraction and mass. Comparison of model-based analysis of ECG-gated (99m)Tc-SPECT and ¹8F-FDG-PET.

Khorsand A, Gyöngyösi M, Sochor H, Maurer G, Karanikas G, Dudczak R, Schuster E, Porenta G, Graf S.

Nuklearmedizin. 2011;50(1):9-14.

Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting o    f MRI guided adaptive radiotherapy in cervical cancer.

Schuetz M, Schmid MP, Pötter R, Kommata S, Georg D, Lukic D, Dudczak R, Kletter K, Dimopoulos J, Karanikas G, Bachtiary B.

Acta Oncol. 2010 Oct;49(7):941-7.

Cytokine profiling of human peripheral blood CD4+ T lymphocytes reveals a new Th-subpopulation (Th6) characterized by IL-6.

Azizi-Semrad U, Krenbek D, Hofbauer G, Karanikas G, Maldonado-Gonzalez E, Pietschmann P, Willheim M.

Eur Cytokine Netw. 2010 Jun;21(2):105-15.

Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the bodys red cell volume.

Adlbrecht C, Kommata S, Hülsmann M, Szekeres T, Bieglmayer C, Strunk G, Karanikas G, Berger R, Mörtl D, Kletter K, Maurer G, Lang IM, Pacher R.

Eur Heart J. 2008 29(19):2343-50.

High-resolution contrast-enhanced, susceptibility-weighted MR imaging at 3T in patients with brain tumors: correlation with positron-emission tomography and histopathologic findings.

Pinker K, Noebauer-Huhmann IM, Stavrou I, Hoeftberger R, Szomolanyi P, Karanikas G, Weber M, Stadlbauer A, Knosp E, Friedrich K, Trattnig S.

Am J Neuroradiol. 2007 28(7):1280-6

Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients

Pötzi C, Moameni A, Karanikas G, Preitfellner J, Becherer A, Pirich C, Dudczak R.

Clin Endocrinol (Oxf). 2006;65(4):519-23.

[18F]FETO: metabolic considerations

Ettlinger DE, Wadsak W, Mien LK, Machek M, Wabnegger L, Rendl G, Karanikas G, Viernstein H, Kletter K, Dudczak R, Mitterhauser M.

Eur J Nucl Med Mol Imaging. 2006;33(8):928-31.

Antibiotic abscess penetration: fosfomycin levels measured in pus and simulated concentration-time profiles

Sauermann R, Karch R, Langenberger H, Kettenbach J, Mayer-Helm B, Petsch M, Wagner C, Sautner T, Gattringer R, Karanikas G, Joukhadar C

Antimicrob Agents Chemother. 2005 49(11):4448-54.

PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma  residuals.

Becherer A, De Santis M, Karanikas G, Szabo M, Bokemeyer C, Dohmen BM, Pont J,  Dudczak R, Dittrich C, Kletter K.

Eur J Radiol. 2005;54(2):284-8.

Imaging of advanced neuroendocrine tumors with 18F-FDOPA PET.

Becherer A, Szabó M, Karanikas G, Wunderbaldinger P, Angelberger P, Raderer M, Kurtaran A, Dudczak, R, Kletter K.

J Nucl Med 2004; 45:361-365.

Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine.

Becherer A, Karanikas G, Szabo M, Zettinig G, Asenbaum S, Marosi C, Henk C, Wunderbaldinger P, Czech T, Wadsak W, Kletter K.

Eur J Nucl Med Mol Imaging 2003; 30:1561-7.

Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation.

Becherer A, Mitterbauer M, Jaeger U, Kalhs P, Greinix HT, Karanikas G, Potzi C, Raderer M, Dudczak R, Kletter K.

Leukemia 2002; 16:260-7.

Influence of drugs on myocardial iodine-123 metaiodobenzylguanidine uptake in rabbit myocardium.

Mayer S, Karanikas G, Rodrigues M, Sinzinger H.

Eur J Nucl Med 2000; 27:340-5.

[11C] methionine and [18F] fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme.

Pötzi C, Becherer A, Marosi C, Karanikas G, Szabo M, Dudczak R, Kletter K, Asenbaum S.

J Neurooncol. 2007 Sep;84(3):305-14

Calcitonin Measurements for Early Detection of Medullary Thyroid Carcinoma or its  Premalignant Conditions in Hashimoto´s Thyroiditis.

Schuetz M, Beheshti M, Oezer S, Novotny C, Paul M, Hofmann A, Bieglmayer C,    Niederle B, Kletter K, Dudczak R, Karanikas G, Pirich C.

Anticancer Research 2006, 26:723-728.

T lymphocyte cytokine production patterns in hashimoto patients with elevated calcitonin levels and their relationship to tumor initiation.

Schuetz M, Duan H, Wahl K, Pirich C, Antoni A, Kommata S, Kletter K, Dudczak R, Karanikas G, Willheim M.

Anticancer Res. 2006;264591-6.

FDG-PET in adrenocortical carcinoma.

Becherer A, Vierhapper H, Potzi C, Karanikas G, Kurtaran A, Schmaljohann J, Staudenherz A, Dudczak R, Kletter K.

Cancer Biother Radiopharm 2001; 16:289-95

Radiation exposure from patients treated with 165Dy-ferric hydroxide.

Havlik E, Pirich C, Preitfellner J, Karanikas G, Schaffarich P, Hefner A, Sinzinger H.

Nucl Med Commun 2001; 22:79-82.

Synthesis of Cobalt – 55 / 57 – coplexes for radiolabelling of platelets as a potential PET imaging agent.

Schmaljohann J, Karanikas G, Sinzinger H.

J Labelled Cpd Radiopharm 2001; 44:395-403.

Radioactive contamination of contact lenses during radioiodine therapy.

Zettinig G, Karanikas G, Hanselmayer G, Havlik E, Dudczak R.

Nucl Med Commun 2000; 21:955-7.

6-Oxo-PGF1a and 8-epi-PGF2a in human atherosclerotic vascular tissue.

Oguogho A, Karanikas G, Kritz H, Riehs G, Wagner O, Sinzinger H.

Prostaglandins Leukot Essent Fatty Acids 1999; 60:129-34

The economy class syndrome–a survey of 19 cases.

Sinzinger H, Karanikas G, Kritz H, O’Grady J, Vinazzer H.

Vasa 1999; 28:199-203

99m-Tc-tetrofosmin scintigraphy and breast cancer.

Berghammer P, Obwegeser R, Mulauer-Ertl S, Karanikas G, Wiltschke C, Kubista E, Sinzinger H, Zielinski C.

Gynecol Oncol 1999 73:87-90. (Review)

99mTc-Furifosmin uptake by melanoma cells.

Meghdadi S, Chehne F, Rodrigues M, Karanikas G, Pehamberger H, Schlagbauer-Wadl H, Sinzinger H.

Radioactive Isotopes in Clinical Medicine and Research XXIII, Birkhäuser Verlag, 1999; 175-9. (Kongressbuchbeitrag)

Radiation exposure deriving from patients treated with 165Dy-Ferric hydroxide.

Havlik E, Karanikas G, Pirich Ch, Preitfellner J, Schaffarich P, Sinzinger H.

Radioactive Isotopes in Clinical Medicine and Research XXIII, Birkhäuser Verlag, 1999; 303-6. (Kongressbuchbeitrag)

Factors influencing myocardial uptake of MIBG in-vitro.

Mayer S, Karanikas G, Rodrigues M, Granegger S, Sinzinger H.

Radioactive Isotopes in Clinical Medicine and Research XXIII, Birkhäuser Verlag, 1999; 541-4. (Kongressbuchbeitrag)

Technetium-99m-tetrofosmin: a new agent for melanoma imaging?

Meghdadi S, Karanikas G, Schlagbauer-Wadl H, Jansen B, Chehne F, Rodrigues M, Pehamberger H, Sinzinger H.

Anticancer Res 1998; 18:2759-62.

Acetylsalicylic acid is unlikely to beneficially interfere with radiation-induced vasculopathy.

Sinzinger H, Karanikas G, Kritz H.

Acta Oncol 1997; 36:341. (Letter, IF: 3.137)

Thromboresistance is a vascular property.

Sinzinger H, Karanikas G, Kritz H, Granegger S, Mosing B.

Radioactive Isotopes in Clinical Medicine and Research XXII, Birkhäuser Verlag, 1997; 197-204. (Kongressbuchbeitrag)

Passive smoking and platelet thromboxane.

Schmid P, Karanikas G, Kritz H, Pirich C, Stamatopoulos Y, Peskar BA, Sinzinger H.

Thromb Res 1996; 81:451-60.

Bradykinin formation during processing for cellular labelling may cause side-effects.

Rodrigues M, Karanikas G, Granegger S, Sinzinger H.

Eur J Nucl Med 1996; 23:857-8. (Letter)

Methodological reappraisal of platelet radiolabelling with 111Indium.

Rodrigues M, Karanikas G, Granegger S, Sinzinger H.

Nucl Med Biol 1996; 23:1023-5. (Letter)

Radiation-induced vascular damage.

Kritz H, Ulm MR, Karanikas G, Sinzinger H.

Vasa 1995; 24:392-5.

[Thrombocyte function of healthy probands taking 50 mg of acetylsalicylic acid per day]

Sinzinger H, Kritz H, Pirich C, Karanikas G, Kurtaran A, Banyai M, Peskar BA, Rehak P.

Wien Klin Wochenschr 1995; 107:457-63.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.